Article

September 11, 2020

AJMC® in the Press, September 11, 2020

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An opinion piece published by The Mercury cited an article published on AJMC.com, the website of The American Journal of Managed Care^®. The article, titled “A Timeline of COVID-19 Developments in 2020,” took a look at how the coronavirus disease 2019 pandemic evolved and progressed from January to June 2020.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS

Mehmet Oz, MD, MBA

Hira Ghani, DO, discusses underdiagnosed skin conditions in children

Nicole Bajic, MD

World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com

2 experts in this video

Related Content

Child standing on scale | Image credit: Protsenko Dmitriy - stock.adobe.com

July 26th 2025

How to Utilize a Multimodal Treatment Approach for Childhood Obesity

With obesity rates rising sharply, the American Academy of Pediatrics calls for multimodal strategies to address the crisis in youth.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

anaphylaxis training. | Image Credit: Flex_Point_Security - stock.adobe.com

July 25th 2025

AllergyAware E-Learning Training Program Boosts Anaphylaxis Preparedness in School Staff

Cameron Santoro

The AllergyAware e-learning course effectively trained school personnel on anaphylaxis management, significantly improving their knowledge and confidence in using epinephrine auto-injectors, despite some technical and pacing issues reported by users.

Managed Care Cast

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Headshots of Robyn Guo Ku, BS, a medical student; Tarannum Jaleel, MD, MS; and Daniela Kroshinsky, MD, MPH | Background image credit: ipopba - stock.adobe.com

July 25th 2025

Navigating Pediatric Hidradenitis Suppurativa: A Q&A on Early Diagnosis and Effective Treatment

Laura Joszt, MA Robyn Guo Ku Tarannum Jaleel, MD, MS Daniela Kroshinsky, MD, MPH

Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared with infliximab in children.

Topical cream for AD | Image credit: Ladanifer - stock.adobe.com

July 25th 2025

Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD

A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).

Related Content

Child standing on scale | Image credit: Protsenko Dmitriy - stock.adobe.com

July 26th 2025

How to Utilize a Multimodal Treatment Approach for Childhood Obesity

With obesity rates rising sharply, the American Academy of Pediatrics calls for multimodal strategies to address the crisis in youth.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

anaphylaxis training. | Image Credit: Flex_Point_Security - stock.adobe.com

July 25th 2025

AllergyAware E-Learning Training Program Boosts Anaphylaxis Preparedness in School Staff

Cameron Santoro

The AllergyAware e-learning course effectively trained school personnel on anaphylaxis management, significantly improving their knowledge and confidence in using epinephrine auto-injectors, despite some technical and pacing issues reported by users.

Managed Care Cast

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Headshots of Robyn Guo Ku, BS, a medical student; Tarannum Jaleel, MD, MS; and Daniela Kroshinsky, MD, MPH | Background image credit: ipopba - stock.adobe.com

July 25th 2025

Navigating Pediatric Hidradenitis Suppurativa: A Q&A on Early Diagnosis and Effective Treatment

Laura Joszt, MA Robyn Guo Ku Tarannum Jaleel, MD, MS Daniela Kroshinsky, MD, MPH

Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared with infliximab in children.

Topical cream for AD | Image credit: Ladanifer - stock.adobe.com

July 25th 2025

Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD

A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions